Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: Peru Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20081
20111
20131
20181
20191
20202
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University2
Merck Sharp & Dohme LLC2
Agenus Inc.1
Eli Lilly and Company1
GlaxoSmithKline1
Gynecologic Oncology Group1
Hoffmann-La Roche1
International Agency for Research on Cancer1
International Atomic Energy Agency1
Latin American Cooperative Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms15
Papillomavirus Infections2
Adenocarcinoma1
Carcinoma1
HIV Infections1
Neoplasms1
Uterine Cervical Dysplasia1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.